Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-25

Clinical Trial Update: Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies [NA]

View source ↗

Summary

A terminated clinical trial investigating procurement of leukapheresis products from end-stage liver disease patients for immunological studies; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwestern University | Conditions: End Stage Liver Disease | NA | Status: TERMINATED | Results posted: 2019-09-25